Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Life Sciences
What Are The Most Appropriate Treatments, Preventions And Family Planning Options For Patients With Factor V Leiden?, Simha Wolf
The Science Journal of the Lander College of Arts and Sciences
The management of Venous Thromboembolism in terms of treatments and prevention has been well researched for patients who have been discovered as positive for Factor V Leiden genetic clotting disorder, in either the homozygous or the heterozygous genotype. In fact, the research and development of new agents called Direct oral anticoagulants aim to treat and prevent clotting events while minimizing the risks of bleeding. Although several risk factors have been identified in relation to VTE, Factor V Leiden mutation presents a seemingly higher risk due to its unpredictable incidences of clotting events, even in patients with optimal health characteristics. Yet, …
The Effects Of Aging On Skeletal Muscle Atp Production, Chaya Abboudi
The Effects Of Aging On Skeletal Muscle Atp Production, Chaya Abboudi
The Science Journal of the Lander College of Arts and Sciences
The study of the aging process and its prevention is an incredibly popular field; the natural course of the human body is to age and theories abound on how to avoid it. Age affects every system and pathway of the body and alters many of the bodily functions. This paper, using articles from Touro’s library database examines the different areas in which aging negatively affects ATP production. The multifaceted process associated with the production of ATP in the human body was analyzed. Several features such as the mitochondria, physical activity, and hormones are linked to ATP production and the relationship …
A Multi-Domain Approach To Prevention And Reversal Of Cognitive Decline, Chanah Oberlander
A Multi-Domain Approach To Prevention And Reversal Of Cognitive Decline, Chanah Oberlander
The Science Journal of the Lander College of Arts and Sciences
Incidence of dementia has been on the rise over the last few decades and it is projected that more than 130 million people will be affected by dementia worldwide by 2050. The underlying cause remains incompletely determined, and despite numerous clinical trials, no drug to date has proven effective in preventing or reversing symptoms of cognitive decline due to Alzheimer’s disease. The amyloid hypothesis as a basis for drug development of Alzheimer’s disease has thus far proven to be ineffective, suggesting that perhaps a new approach is required. New studies have shown the efficacy of a multi-domain approach which targets …